UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 1 filers reported holding UNIQURE NV in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,852,493 | -41.4% | 2,064,455 | 0.0% | 0.29% | -31.5% |
Q2 2023 | $23,658,654 | -43.1% | 2,064,455 | 0.0% | 0.43% | -47.4% |
Q1 2023 | $41,578,124 | +5.0% | 2,064,455 | +18.1% | 0.82% | +7.7% |
Q4 2022 | $39,617,072 | +32.2% | 1,747,555 | +9.4% | 0.76% | +36.3% |
Q3 2022 | $29,960,000 | +83.7% | 1,597,000 | +82.5% | 0.56% | +88.5% |
Q2 2022 | $16,307,000 | -1.8% | 874,849 | -4.8% | 0.30% | +9.7% |
Q1 2022 | $16,611,000 | +36.8% | 919,249 | +57.0% | 0.27% | +72.4% |
Q4 2021 | $12,145,000 | -35.2% | 585,574 | 0.0% | 0.16% | -24.3% |
Q3 2021 | $18,744,000 | +29.2% | 585,574 | +24.3% | 0.21% | +40.1% |
Q2 2021 | $14,512,000 | -55.6% | 471,174 | -51.4% | 0.15% | -51.8% |
Q1 2021 | $32,648,000 | -6.8% | 969,079 | 0.0% | 0.30% | -0.3% |
Q4 2020 | $35,013,000 | -1.9% | 969,079 | 0.0% | 0.31% | -31.8% |
Q3 2020 | $35,691,000 | -18.3% | 969,079 | 0.0% | 0.45% | -27.0% |
Q2 2020 | $43,667,000 | -6.5% | 969,079 | -1.5% | 0.62% | -21.7% |
Q1 2020 | $46,690,000 | -39.8% | 983,979 | -9.0% | 0.78% | -29.1% |
Q4 2019 | $77,519,000 | +134.6% | 1,081,765 | +28.8% | 1.11% | +76.6% |
Q3 2019 | $33,047,000 | -52.9% | 839,600 | -6.5% | 0.63% | -42.3% |
Q2 2019 | $70,163,000 | +1775.5% | 897,800 | +83.6% | 1.09% | +2427.9% |
Q3 2016 | $3,741,000 | +159.8% | 489,000 | +150.3% | 0.04% | +186.7% |
Q2 2016 | $1,440,000 | -34.4% | 195,400 | +5.7% | 0.02% | -34.8% |
Q1 2016 | $2,195,000 | – | 184,800 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |